Diagnostic significance of FDG-PET and argyrophilic nucleolar organizer regions (AgNORs) in oral squamous cell carcinoma

Oral Oncology

Volumn 40, Issue 2, 2004, Pages 190-198

  Nakamura, Mikiko ^a   Sano, Kazuo ^a   Kitagawa, Yoshimasa ^a   Ogasawara, Toshiyuki ^a   Nishizawa, Sadahiko ^a   Yonekura, Yoshiharu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

AgNORs; Neoadjuvant chemoradiotherapy; Positron emission tomography (PET); Proliferation; Squamous cell carcinoma

Indexed keywords

CARBOPLATIN; FLUORODEOXYGLUCOSE; FLUOROURACIL; PIRARUBICIN;

ADULT; AGED; ARGYROPHILIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CELL VIABILITY; CHROMOSOME NOR; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; MALE; MOUTH CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY; TUMOR CELL;

EID: 0346158527     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(03)00151-9     Document Type: Article

References (31)

1. Kitagawa Y., Nishizawa S., Sano K., Ogasawara T., Nakamura M., Sadato N.et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med. 44(2):2003;198-206.
2. Bar-Shalom R., Valdivia A.Y., Blaufox M.D. PET imaging in oncology. Semin Nucl Med. 30(3):2000;150-185.
3. Kitagawa Y., Nishizawa S., Sano K., Sadato N., Maruta Y., Ogasawara T.et al. Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 93(2):2002;202-207.
4. Kitagawa Y., Sadato N., Azuma H., Ogasawara T., Yoshida M., Ishii Y.et al. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms. J Nucl Med. 40:1999;1132-1137.
5. Kitagawa Y., Sano K., Nishizawa S., Nakamura M., Ogasawara T., Sadato N.et al. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging. 30:2003;63-71.
6. Howell W.M. Selective staining of nucleolus organizer regions (NORs). Busch H., Rothblum L. The cell nucleus. 1982;89-143 Academic, New York.
7. Ploton D., Bobichon H., Adnet J.J. Ultrastructual localization of NOR in nucleoli of human breast cancer tissues using a one-step Ag-NOR staining method. Biol Cell. 43:1982;229-232.
8. Iuchi T., Iwadate Y., Nanba H., Osato K., Saeki N., Yamaura A.et al. Glucose and methionine uptake and proliferative activity in meningiomas. Neurol Res. 21:1999;640-644.
9. 11C Tyrosine PET J Nucl Med. 38:1997;1369-1374.
10. Hermanek P., Sobin L.H. UICC: TNM classification of malignant tumours. 4th ed:1987;Springer-Verlag, Berlin.
11. Freming I.D., Cooper J.S., Henson D.E. AJCC cancer staging manual. 5th ed:1997;Lippincott Williams & Wilkins, Philadelphia.
12. Handbook for reporting result of cancer treatment. 1979;World Health Organization, Geneva.
13. Shimosato Y., Oboshi S., Baba K. Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jap J Clin Oncol. 1:1971;19-35.
14. Delahunt B., Avallon F.A., Ribas J.L., Mostofi K. Gold toning improves the visualization of nucleolar organizer regions in paraffin embedded tissues. Biotech Histochem. 66:1991;316-320.
15. Chiusa L., Galliano D., Formiconi A., Di Primio O., Pich A. High and low risk prostate carcinoma determined by histologic grade and proliferative activity. Cancer. 79:1997;1956-1963.
16. Stokkel M.P., ten Broek F.W., van Rijk P.P. The role of FDG-PET in the clinical management of head and neck cancer. Oral Oncol. 34:1998;466-471.
17. Higashi K., Ueda Y., Yagishita M., Arisaka Y., Sakurai A., Oguchi M.et al. FDG PET measurement of the proliferative potential of non-small cell lung cancer. J Nucl Med. 41:2000;85-92.
18. Vesselle H., Schmidt R.A., Pugsley J.M., Li M., Kohlmyer S.G., Vallieres E.et al. Lung cancer proliferation correlates with [F-18] Fluorodeoxyglucose uptake by positron emission tomography. Clin. Cancer Res. 6:2000;3837-3844.
19. 18F-FDG PET. histologic and immunohistochemical tissue analysis J Nucl Med. 42:2001;9-16.
20. Higashi T., Tamaki N., Torizuka T., Nakamoto Y., Sakahara H., Kimura T. et al. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors. J Nucl Med. 39:1998;1727-1735.
21. Piffko J., Bankfalvi A., Öfner D., Rasch D., Joos U., Schmid K.W. Standardized AgNOR analysis of the invasive tumour front in oral squamous cell carcinomas. J Pathol. 182:1997;450-456.
22. Hammer D.S., Herberhold C., Pfeifer U. Argyrophilic nucleolar organizer region counts in squamous cell carcinomas of the head and neck after irradiation and chemotherapy. Eur Arch Otorhinolaryngol. 255:1998;74-76.
23. Zaitoun A.Z., Ebbs S.R. Quantitative cytological assessment of Ki-67 and AgNORs using computer-digitized image analysis of four clinicopathological breast lesions. Cytopathology. 11:2000;243-254.
24. Böhm J., Kacic V., Gais P., Präuer H.W., Höfler H. Prognostic value of nucleolar organizer regions in neuroendocrine tumours of the lung. Histochemistry. 99:1993;85-90.
25. Sano K., Takahashi H., Fujita S., Inokuchi T., Pe M.B., Okabe H.et al. Prognostic implication of silver-binding nucleolar organizer regions (AgNORs) in oral squamous cell carcinoma. J. Oral Pathol. Med. 20:1991;53-56.
26. Xie X., Angelis P.D., Clausen O.P.F., Boysen M. Prognostic significance of proliferative and apoptotic markers in oral tongue squamous cell carcinomas. Oral Oncol. 35:1999;502-509.
27. Bigras G., Marcelpoil R., Brambilla E., Brugal G. Interest of targeting AgNORs measurement in cycling cells. in vivo cell kinetic evaluation of non-small cell lung cancer Anal Cell Pathol. 11:1996;183-198.
28. Yue L., Iwai M., Furuta I. Evaluation of argyrophilic nucleolar organizer regions in tongue squamous cell carcinomas. Oral Oncol. 35:1999;70-76.
29. Delahunt B., Kittelson J.M., McCredie M.R., Reeve A.E., Stewart J.H., Bilous A.M. Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma. Cancer. 94:2002;658-664.
30. Sirri V., Roussel P., Hernandez-Verdun D. The AgNOR proteins. qualitative and quantitative changes during the cell cycle Micron. 31:2000;121-126.
31. Derenzini M. The AgNORs. Micron. 31:2000;117-120.